Regentis Biomaterials Ltd.
RGNT
Positions held
Your positionsRGNT isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $11.94M | Enterprise value | $3.02M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 1.86 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | -113.6% | Debt / equity | 0.00 |
| Current ratio | 5.62 | Free cash flow | $2.14M | Analyst recommendation | none | Mean target | $10.00 |
| 52w high | $15.50 | 52w low | $1.23 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$13.6M | $4.8M | -$4.1M | -$1.4M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$8.6M | $0.9M | -$1.9M | -$1.4M | — |
Headlines — watch
• [WARN · legal] Regentis Biomaterials Gets Approval for Cartilage Product Manufacturing Process From European Regulator
News
2026-09-18 · IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd.
2026-09-14 · Regentis Biomaterials (RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair
2026-09-11 · Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
2026-08-28 · Regenerative Hydrogel Is Redefining Cartilage Repair as Regentis Advances GelrinC
2026-08-17 · Regentis Biomaterials (RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks
2026-08-03 · Regentis Biomaterials (RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair
2026-07-30 · Regentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C
2026-07-20 · Regentis Biomaterials Obtains Japanese Patent Allowance for Cartilage Repair Treatment
2026-07-16 · Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process
Price (daily)
Full chart · RSI · MACD · patterns